Day two at the FDD Conclave 2025 began with a highly insightful and motivating keynote address by Dr Pavan Bhat, CEO, Inventia Healthcare. The presentation set the tone for the day by emphasising the critical role of formulation scientists in addressing global healthcare challenges through innovation, responsibility, and patient-centric thinking.
Dr Bhat reflected on the journey that begins at the lab bench, where formulation starts with literature reviews, patents, de-formulation, and countless trials. At this stage, the focus lies in getting the science right. Dr Bhat emphasised how the field is brimming with opportunities and how rapidly new molecules, markets, and regulations would reshape the landscape.
The dosage form does more than deliver the drug; it delivers access. Dr Bhat emphasised its importance by stating that what scientists formulate today defines care tomorrow.
He conveyed that formulators must continuously adapt to evolving scientific, regulatory and operational demands and not be deterred by failure. He also explained how speed is now part of innovation. Innovation is not just doing it better. It’s doing it faster, with fewer iterations, and fewer regulatory surprises Dr Bhat reflected on his journey from lab to leadership, highlighting how his scientific focus evolved into a broader business perspective.
The shift, he noted, wasn’t just technical, but in thinking directionally, aligning science with realworld outcomes and responsibilities. Finally, sharing insights from his experience, he delivered a message to the future formulators. Future formulators must adapt to scientific, regulatory, and operational forces. They must focus on bridging science and public health by translating global health needs into precise, stable, and accessible formulations.